Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_2
2
33%
Ph phase_4
3
50%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 43 (60.0%)

Trials by Status

terminated117%
completed467%
unknown117%

Recent Activity

0 active trials
Showing 5 of 6
terminatedphase_2

A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)

NCT00651807
completedphase_4

Breastfeeding Etonogestrel Implant Study

NCT03978598
unknownphase_2

Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus

NCT05791799
completed

Abnormal Uterine Bleeding and Progestin-only Contraceptives

NCT03398811
completedphase_4

A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy

NCT02082652
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00651807Phase 2

A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)

Terminated
NCT03978598Phase 4

Breastfeeding Etonogestrel Implant Study

Completed
NCT05791799Phase 2

Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus

Unknown
NCT03398811

Abnormal Uterine Bleeding and Progestin-only Contraceptives

Completed
NCT02082652Phase 4

A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy

Completed
NCT02480647Phase 4

Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6